| Execution period | 1 year |
|---|
BSE filing, NSE: SREEJAYA. Summary written from the filing by ALFA Finder's alert engine.
Sparkle Gold Rock Ltd: key numbers
- Share price
- ₹69.99
- Market cap
- ₹31.34 Cr
- Revenue (annual)
- ₹111.6 Cr
- Net profit (annual)
- ₹4.14 Cr
- P/E (TTM)
- 7.3×Sector 49.5×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sparkle Gold Rock Ltd
All →Sparkle Gold Rock Other Announcement
Sparkle Gold Rock Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations.
Sparkle Gold Rock Management Change
Sparkle Gold Rock Limited has appointed Ms. Durga Pallavi Tekumalla as a Non-Executive Independent Director. The appointment is for a five-year term effective from September 30, 2026.
- Execution
- 5 years
Sparkle Gold Rock Annual General Meeting
Sparkle Gold Rock Limited held its Annual General Meeting on September 30, 2026. Key agenda items included adoption of financial results and increasing authorised share capital.
Sparkle Gold Rock Annual Report
Sparkle Gold Rock Ltd has filed its Annual Report for the financial year 2025-26, including notice of the 35th Annual General Meeting.
Sparkle Gold Rock Annual General Meeting
Sparkle Gold Rock Limited announced its 35th Annual General Meeting scheduled for September 30, 2026. The agenda includes financial adoption, auditor appointment, and authorized share capital increase.
Sparkle Gold Rock Management Change
Sparkle Gold Rock Limited has appointed Ms. Durga Pallavi Tekumalla as an Additional Non-Executive Independent Director, effective September 4, 2026.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.